Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cureus|February 13, 2024
Observational, Multicenter, Retrospective, Study on the Usage Patterns of the Fixed Dose Combination of Glimepiride, Metformin, and Voglibose in Type 2 Diabetes ManagementParamesh Shamanna, Pankaj Kumar Jha, Altaf Makwana, et al.
Frontiers in Endocrinology|December 5, 2024
Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic controlParamesh Shamanna, Shashank Joshi, Mohamed Thajudeen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 1, 2023
Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled StudyShashank Joshi, Paramesh Shamanna, Mala Dharmalingam, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 25, 2020
Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective AnalysisParamesh Shamanna, Banshi Saboo, Suresh Damodharan, et al.
Scientific Reports|July 22, 2021
Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment ProgramParamesh Shamanna, Mala Dharmalingam, Rakesh Sahay, et al.
The Journal of the Association of Physicians of India|February 10, 2025
Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)Banshi Saboo, Deepak Khandelwal, Piyush Desai, et al.
JACC. Advances|October 7, 2024
Digital Twin in Managing Hypertension Among People With Type 2 Diabetes: 1-Year Randomized Controlled TrialParamesh Shamanna, Shashank Joshi, Mala Dharmalingam, et al.
Plos One|April 10, 2014
Blood pressure control with a single-pill combination of indapamide sustained-release and amlodipine in patients with hypertension: the EFFICIENT studyUday Jadhav, Jagdish Hiremath, Deepak J Namjoshi, et al.
Journal of Diabetes and Its Complications|March 22, 2014
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)Julio Rosenstock, Markolf Hanefeld, Paramesh Shamanna, et al.
Clinical Diabetes and Endocrinology|November 15, 2021
Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort studyParamesh Shamanna, Shashank Joshi, Lisa Shah, et al.
Pageof 2